Page last updated: 2024-11-06

adipostatin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Adipostatin A is a natural product isolated from the bacterium Streptomyces sp. It exhibits potent inhibitory activity against adipogenesis, the process of fat cell formation. It works by targeting the transcription factor PPARĪ³, a key regulator of adipogenesis. Adipostatin A has shown promise in preclinical studies as a potential therapeutic agent for obesity and related metabolic disorders. Its mechanism of action and unique structure make it a valuable tool for understanding adipogenesis and exploring novel anti-obesity strategies. Researchers are actively investigating its therapeutic potential and exploring its synthesis and modification to enhance its potency and bioavailability.'

adipostatin A: allergen from cashew nut shell oil; as adipostatin found as inhibitor of glycerol-3-phosphate dehydrogenase from Streptomyces; Also found in bees; do not confuse with cardol, RN 57486-25-6, MF unknown; [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cardol : Resorcinol substituted at position 5 by a pentadecyl chain. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID76617
CHEMBL ID98610
CHEBI ID2120
SCHEMBL ID406402
MeSH IDM0122613

Synonyms (40)

Synonym
u1fu33ycg0 ,
unii-u1fu33ycg0
nsc 776
1,3-benzenediol, 5-pentadecyl-
einecs 221-599-7
adipostatin a
5-n-pentadecylresorcinol
CHEBI:2120 ,
5-pentadecylbenzene-1,3-diol
5-pentadecyl-1,3-benzenediol
resorcinol, 5-pentadecyl-
resorcinol, pentadecyl-
resorcinol, 5-pentadecyl
3158-56-3
1, 5-pentadecyl-
nsc-776
5-pentadecylresorcinol
cardol
nsc776 ,
CHEMBL98610
3-pentadecylresorcinol
5-pentadecyl resorcinol
EPITOPE ID:122679
5-(n-pentadecyl)resorcinol
3-n-pentadecyl-5-hydroxyphenol
DTXSID7062875
SCHEMBL406402
5-pentadecyl-1,3-benzenediol #
KVVSCMOUFCNCGX-UHFFFAOYSA-N
LMPK15030012
5-pentadecylresorcinol, analytical standard
5-pentadecyl-resorcinol
cardol c15:0
Q4682945
BCP33965
5-pentadecylresorcinol;cardol;5-pentadecylbenzene-1,3-diol
bdbm50555908
CS-0066831
HY-116934
AKOS040758955
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 1.1.5.3 (glycerol-3-phosphate dehydrogenase) inhibitorAn EC 1.1.5.* (oxidoreductase acting on donor CH-OH group, quinone or similar compound as acceptor) inhibitor that interferes with the action of glycerol-3-phosphate dehydrogenase (EC 1.1.5.3).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
5-alkylresorcinolA resorcinol compound having an alkyl substituent at the 5-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin G/H synthase 1Ovis aries (sheep)IC50 (µMol)5.61000.00032.177410.0000AID1704051
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)2.36000.00010.995010.0000AID1704052
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (59)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID277220Cytotoxicity against human MCF7 cells2007Journal of natural products, Feb, Volume: 70, Issue:2
Cytotoxic 5-alkylresorcinol metabolites from the leaves of Grevillea robusta.
AID379521Inhibition of PTP1B at 50 uM2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID332399Cytotoxicity against human MCF7 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID604335Growth inhibition of human BT20 cells2011Bioorganic & medicinal chemistry, Jul-01, Volume: 19, Issue:13
5-alk(en)ylresorcinols as the major active components in wheat bran inhibit human colon cancer cell growth.
AID277221Cytotoxicity against human NCI-H460 cells2007Journal of natural products, Feb, Volume: 70, Issue:2
Cytotoxic 5-alkylresorcinol metabolites from the leaves of Grevillea robusta.
AID376622Antimicrobial activity against Candida krusei ATCC 6258 by broth dilution method2006Journal of natural products, Apr, Volume: 69, Issue:4
5-alkylresorcinols from Merulius incarnatus.
AID277222Cytotoxicity against human SF268 cells2007Journal of natural products, Feb, Volume: 70, Issue:2
Cytotoxic 5-alkylresorcinol metabolites from the leaves of Grevillea robusta.
AID68982Ability to inhibit autophosphorylation of NR11 and/or transphosphorylation of NR1 TCS proteins from E. coli; NT-Not tested1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems.
AID332396Toxicity in brine shrimp larvae1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID379522Inhibition of thrombin at 50 uM2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID604337Growth inhibition of human MCF7 cells2011Bioorganic & medicinal chemistry, Jul-01, Volume: 19, Issue:13
5-alk(en)ylresorcinols as the major active components in wheat bran inhibit human colon cancer cell growth.
AID604338Growth inhibition of human NCI-H460 cells2011Bioorganic & medicinal chemistry, Jul-01, Volume: 19, Issue:13
5-alk(en)ylresorcinols as the major active components in wheat bran inhibit human colon cancer cell growth.
AID379518Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID1704053Selectivity index, ratio of IC50 for ovine COX-1 to IC50 for human recombinant COX-22020European journal of medicinal chemistry, Oct-15, Volume: 204Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
AID332456Inhibition of mushroom tyrosinase assessed as oxidation of L-DOPA1994Journal of natural products, Apr, Volume: 57, Issue:4
Tyrosinase inhibitors from Anacardium occidentale fruits.
AID376621Antimicrobial activity against Candida glabrata ATCC 90030 by broth dilution method2006Journal of natural products, Apr, Volume: 69, Issue:4
5-alkylresorcinols from Merulius incarnatus.
AID376623Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by broth dilution method2006Journal of natural products, Apr, Volume: 69, Issue:4
5-alkylresorcinols from Merulius incarnatus.
AID332397Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumors in potato by disk test relative to control1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID379516Cytotoxicity against human A549 cells after 96 hrs by MTT assay2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID74452Skin test reactivity (intensity of erythema and edema) was measured in guinea pig sensitized to poison ivy urushiol by Draize method1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
AID1704058Inhibition of human recombinant 5-LOX assessed as reduction in LTB4 level using 800 uM arachidonic acid as substrate at 5 uM preincubated with enzyme for 10 mins followed by substrate addition and measured after 10 mins by ELISA relative to control2020European journal of medicinal chemistry, Oct-15, Volume: 204Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
AID1704051Inhibition of ovine COX-1 assessed as reduction in PGE2 level using 10 uM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA2020European journal of medicinal chemistry, Oct-15, Volume: 204Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
AID332455Inhibition of mushroom tyrosinase assessed as oxidation of L-DOPA at 0.8 mM1994Journal of natural products, Apr, Volume: 57, Issue:4
Tyrosinase inhibitors from Anacardium occidentale fruits.
AID332400Cytotoxicity against human HT-29 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1704052Inhibition of human recombinant COX-2 assessed as reduction in PGE2 level using 10 uM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA2020European journal of medicinal chemistry, Oct-15, Volume: 204Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
AID332398Cytotoxicity against human A549 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID73986Allergenic cross-reactivity was expressed as number of guinea pig with a positive skin reaction versus number tested upon sensitizing them to poison ivy urushiol; 5/91986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
AID379517Cytotoxicity against human A2780 cells after 96 hrs by MTT assay2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID40627Ability to inhibit autophosphorylation of KinA and/or Sp0F TCS proteins from Bacillus subtilis1999Bioorganic & medicinal chemistry letters, Oct-18, Volume: 9, Issue:20
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems.
AID379519Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID604336Growth inhibition of mouse FM3A cells2011Bioorganic & medicinal chemistry, Jul-01, Volume: 19, Issue:13
5-alk(en)ylresorcinols as the major active components in wheat bran inhibit human colon cancer cell growth.
AID604339Growth inhibition of human HeLa cells2011Bioorganic & medicinal chemistry, Jul-01, Volume: 19, Issue:13
5-alk(en)ylresorcinols as the major active components in wheat bran inhibit human colon cancer cell growth.
AID379520Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay2006Journal of natural products, Nov, Volume: 69, Issue:11
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes.
AID75775The dose which shows the cross-reactivity with guinea pig sensitized to poison ivy urushiol1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
AID376620Antimicrobial activity against Candida albicans ATCC 90028 by broth dilution method2006Journal of natural products, Apr, Volume: 69, Issue:4
5-alkylresorcinols from Merulius incarnatus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (11.11)18.7374
1990's8 (22.22)18.2507
2000's11 (30.56)29.6817
2010's10 (27.78)24.3611
2020's3 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.15 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (5.41%)4.05%
Observational0 (0.00%)0.25%
Other35 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]